HOME >> MEDICINE >> NEWS
Electromagnetic breast imaging tested as alternative to mammography

OAK BROOK, Ill. Researchers are testing three promising new electromagnetic imaging techniques to help detect breast abnormalities, including cancer. The findings of the benchmark study will be published in the May issue of the journal Radiology.

For the study, which is part of the five-year Alternative Breast Imaging Project funded by a grant from the National Cancer Institute, researchers at Dartmouth Medical School in Lebanon, N.H., imaged the breasts of 23 women using a combination of three new techniques:

  • electrical impedance (EI)spectroscopy
  • microwave imaging (MI) spectroscopy
  • near-infrared (NIR) spectroscopy

The new imaging techniques use low-frequency electrical currents, microwaves and infrared light, respectively, to create a computerized image of a cross-section of breast tissue. Each technology can identify various properties, including the amount of oxygenated blood flow in the breast and how the tissue absorbs light and stores and conducts an electrical charge. These properties help researchers estimate specific breast characteristics, which differ in normal and diseased tissue.

"This study was the first stepping stone in our ongoing research to gain a better understanding of the electromagnetic properties of breast tissue," said Steven Poplack, M.D., professor of radiology at Dartmouth Medical School and co-director of breast imaging and mammography at Dartmouth-Hitchcock Medical Center. "Once we establish normal ranges for specific breast characteristics, we'll begin working on recognizing breast abnormalities, including cancer."

The research team is exploring alternative breast imaging techniques to address some of the limitations of mammography, a diagnostic exam recommended for women over age 40 as a screening for breast cancer.

"If we can offer an alternative screening technique that addresses radiation concerns and is also more comfortable, the hope is
'"/>

Contact: Maureen Morley
mmorley@rsna.org
630-590-7754
Radiological Society of North America
3-May-2004


Page: 1 2

Related medicine news :

1. Treatment-Resistant Depression: Results of Latest Electromagnetic Stimulation Study Show Promise
2. International breast cancer prevention study launches in the United States and Canada
3. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
4. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
5. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
6. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women
7. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
8. Postmenopausal breast cancer survivors at increased risk for bone fractures
9. Nursing mothers having surgery -- How long a wait to breastfeed safely?
10. Researchers close in on breast cancer vaccine
11. Simple question from your doctor can help identify your risk for breast cancer

Post Your Comments:
(Date:6/19/2013)... Salt Lake City, UT (PRWEB) June 19, 2013 ... wellness companies : , In July 2013, Orriant ... optimize their participation rates, and maintain compliance with ... implemented allowing employees to receive wellness incentives if ... Orriant has announced they have been compliant with ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 As ... cancer continue to mount in courts throughout the U.S., ... Drug Administration (FDA) recently held a meeting to discuss ... as incretin mimetics. According to a June 12th ... from the makers of Januvia and similar drugs, following ...
(Date:6/19/2013)... In what is believed to be the largest follow-up ... hereditary dystonia a movement disorder that can cause ... report good success rates and lasting benefits. , Michele ... at Cedars-Sinai Medical Center,s Department of Neurology, and Ron ... at Beth Israel Deaconess Medical Center in Boston, published ...
(Date:6/19/2013)... disparities between minority and white clients in success ... these disparities vary widely from state to state. ... states there,s something amiss," says Stephan Arndt, Ph.D., ... strong racial and ethnic disparities for people in ... successfully, and those disparities are something we need ...
(Date:6/19/2013)... The Movement Disorders Center ... urologists with specialists in physical therapy, occupational therapy ... and their family members to manage diseases and ... also have the opportunity to participate in the ... disorders can be relentlessly progressive and disabling conditions, ...
Breaking Medicine News(10 mins):Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3Health News:Abington Memorial Hospital’s Neurosciences Institute Opens Movement Disorders Center 2
(Date:6/19/2013)... MUMBAI, India , June 19, ... Book Bureau has recently added DrugPatentWatch ... Databases. ( http://www.bharatbook.com/drugpatentwatch-tour.pdf ) ... DrugPatentWatch provides comprehensive information on pharmaceutical, ... value-added information supports the critical business ...
(Date:6/19/2013)... --  Nektar Therapeutics (Nasdaq: NKTR ) today ... study for NKTR-181, a first-in-class, opioid analgesic molecule ... slow rate of entry is designed to reduce the euphoria ... current opioid analgesics. 1 In the study data being ... in "drug liking" and "feeling high" scores and had highly ...
(Date:6/19/2013)... June 19, 2013 BD Biosciences, a segment of ... a leading global medical technology company, today announced the launch ... latest in its line of high-performance research flow cytometers. ... multicolor analysis with the most compact footprint in its class ... a height of 30" (76.2 cm). Recognizing that space is ...
Breaking Medicine Technology:Drug Patent Watch 2Drug Patent Watch 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2
Cached News: